Download Ovarian Cancer Prevention and Alternative Therapies Potential

Ovarian Cancer Prevention and Alternative Therapies
Potential Causes
Error in DNA Replication Cycle-Primary Cause is Inflammation
Deglycosylation of Gc protein by Nagalase (a protein that inhibits Gc protein from converting into MAF)
from tumor cells
Intracellular Bacteria
Increased Viral Load
Cavitations in the Jaw/Teeth (Root canals)
Increased IgG immune Response
Follow up Testing
AMAS test (Anti-Malignin Antibody in Serum)
Nagalase Testing in Blood: Health Diagnostics and Research Institute
CA-125 levels (Labcorp, Quest)
Alternative Therapies and Prevention
GcMAF
High Dose Vitamin C IV infusions
Diet and Lifestyle Modification (Overhaul)- eliminate sugar, dairy, wheat, etc/ saute foods with proper
oils, reduce stress
Anti-inflammatory Protocols (curcumin, allergy elimination, virus and bacteria eradication, etc)
Carcinosin, Arsenicum homeopathics, Cavitation Removal
Vitamin D supplementation
Treatment of Heavy Metals and Pesticide/chemical exposure
UVBI with ozone (produces aerobic conditions)
IV administration Hydrogen Peroxide
Colonic hydrotherapy, constitutional hydrotherapy
Herbs: Podophyllum peltanum, cat’s claw, chaparral, curcumin, dang shen, blood root, astragalus,
oregano, burdock, sheep sorrel
IV Mistletoe (viscum album), BX antitoxin (Delta Institute of Panama)- Maesa perlarius, Striga asiatica,
Scrophulariaceae, Drosera rotundifolia
References
Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R. Use of Iscador, an extract of
European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and
randomized matched-pair studies nested within a cohort study. Altern Ther Health Med. 2001
May-Jun;7(3):57-66, 68-72, 74-6.
Hancock VK, Knott EK. “Irradiated blood transfusion in treatment of infections,” Northwest
Medicine 1934; 33: 200
Korbelik M, VR Naraparaju, N Yamamoto. The value of serum alpha-N-acetylgalactosaminidase
measurement for the assessment of tumour response to radio- and photodynamic therapy. Br
J Cancer, 77:1009-1014, 1998.
Pacini S, Punzi T, Morucci G, Gulisano M, Ruggiero M. Effects of Vitamin D-binding Proteinderived Macrophage-activating Factor on Human Breast Cancer Cells. Anticancer Res. 2012
Jan;32(1):45-52.
Uto Y, Yamamoto S, Takeuchi R, Nakagawa Y, Hirota K, Terada H, Onizuka S, Nakata E, Hori H.
Effect of the Gc-derived macrophage-activating factor precursor (preGcMAF) on phagocytic
activation of mouse peritoneal macrophages. Anticancer Res. 2011 Jul;31(7):2489-92.
Yamamoto N, Naraparaju VR. 1998. Structurally well-defined macrophage activating factor
derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.
Immunol Cell Biol 76:237–244.
Yamamoto, N., Naraparaju, V. R., and Asbell, S. 0. Deglycosylation of serum vitamin D3-binding
protein leads to immunosuppression in cancer patients. Cancer Res.56:2827-2831,1996.